Sun Pharmaceutical Industries Limited (BOM:524715)
1,885.10
-17.90 (-0.94%)
At close: Nov 20, 2026
BOM:524715 Market Cap
BOM:524715 has a market cap or net worth of 4.52 trillion as of November 20, 2026. Its market cap has increased by 5.65% in one year.
Market Cap
4.52T
Enterprise Value
4.22T
Revenue
616.31B
Global Rank
n/a
Country Rank
n/a
PE Ratio
41.24
ChartMarket Cap Chart
Since February 15, 2001, BOM:524715's market cap has increased from 27.61B to 4.52T, an increase of 16,279.55%. That is a compound annual growth rate of 21.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 4.52T | 9.61% |
| Dec 31, 2025 | 4.13T | -8.83% |
| Dec 31, 2024 | 4.53T | 49.78% |
| Dec 29, 2023 | 3.02T | 25.77% |
| Dec 30, 2022 | 2.40T | 18.41% |
| Dec 31, 2021 | 2.03T | 42.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.52T |
| Divi's Laboratories | 2.97T |
| Laurus Labs | 1.24T |
| Zydus Lifesciences | 1.20T |
| Cipla | 1.14T |
| Mankind Pharma | 1.10T |
| Aurobindo Pharma | 1.04T |
| Glenmark Pharmaceuticals | 747.33B |